Evidence map›Paper›PMID 34850681›Full record

ArticleeLife2021

MCPH1 inhibits Condensin II during interphase by regulating its SMC2-Kleisin interface.

Martin Houlard, Erin E Cutts, Muhammad S Shamim, Jonathan Godwin, David Weisz, Aviva Presser Aiden, Erez Lieberman Aiden, Lothar Schermelleh, Alessandro Vannini, Kim Nasmyth

Open access · goldAbstract read
In one paragraph

Article in eLife, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 35 papers.

0numbers the graph read from it
0cells of the map it votes in
35citing papers in PubMed
2.8field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

35 citing papers in PubMed, 50 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Review
  6. Review
  7. Article
  8. Mitotic genome folding.The Journal of cell biology · 2025
    Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Review
  17. Article
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 3 institutions in 4 countries.

Martin Houlard *Department of Biochemistry, University of Oxford, Oxford, United Kingdom.ORCID 0000-0001-6780-6939
Erin E Cutts *Division of Structural Biology, The Institute of Cancer Research, London, United Kingdom.ORCID 0000-0003-3290-4293
Muhammad S ShamimThe Center for Genome Architecture, Department of Molecular and Human Genetics, Baylor College of Medicine, Houston, United States.
Jonathan GodwinDepartment of Biochemistry, University of Oxford, Oxford, United Kingdom.
David WeiszThe Center for Genome Architecture, Department of Molecular and Human Genetics, Baylor College of Medicine, Houston, United States.
Aviva Presser AidenThe Center for Genome Architecture, Department of Molecular and Human Genetics, Baylor College of Medicine, Houston, United States.
Erez Lieberman AidenThe Center for Genome Architecture, Department of Molecular and Human Genetics, Baylor College of Medicine, Houston, United States.
Lothar SchermellehDepartment of Biochemistry, University of Oxford, Oxford, United Kingdom.ORCID 0000-0002-1612-9699
Alessandro VanniniDivision of Structural Biology, The Institute of Cancer Research, London, United Kingdom.ORCID 0000-0001-7212-5425
Kim NasmythDepartment of Biochemistry, University of Oxford, Oxford, United Kingdom.
Baylor College of Medicine · USUniversity of Oxford · GBInstitute of Cancer Research · CA

Funding

Center for Genome ImagingRM1HG011016 · NHGRI · HARVARD MEDICAL SCHOOL · PI WU, CHAO-TING · 2021 to 2025
$12.2M
GENOME WIDE MAPPING OF LOOPS USING IN SITU HI-CUM1HG009375 · NHGRI · BAYLOR COLLEGE OF MEDICINE · PI LIEBERMAN-AIDEN, EREZ · 2017 to 2021
$4.7M
Cancer Research UK 21536Cancer Research UK 26747Cancer Research UK CR-UK C47547/A21536European Research Council 294401NHGRI NIH HHS RM1 HG011016NHGRI NIH HHS UM1 HG009375Wellcome Trust 091911Wellcome Trust 107457/Z/15/ZWellcome Trust 107935/Z/15/ZWellcome Trust 200818/Z/16/Z
6 · The paper itself

Abstract

Dramatic change in chromosomal DNA morphology between interphase and mitosis is a defining features of the eukaryotic cell cycle. Two types of enzymes, namely cohesin and condensin confer the topology of chromosomal DNA by extruding DNA loops. While condensin normally configures chromosomes exclusively during mitosis, cohesin does so during interphase. The processivity of cohesin's loop extrusion during interphase is limited by a regulatory factor called WAPL, which induces cohesin to dissociate from chromosomes via a mechanism that requires dissociation of its kleisin from the neck of SMC3. We show here that a related mechanism may be responsible for blocking condensin II from acting during interphase. Cells derived from patients affected by microcephaly caused by mutations in the MCPH1 gene undergo premature chromosome condensation. We show that deletion of

Indexed as

AnimalsCell Cycle ProteinsCytoskeletal ProteinsEmbryonic Stem CellsGene Expression RegulationInterphaseMetabolic Networks and PathwaysMiceCell Cycle ProteinsCytoskeletal Proteinsbiochemistrycell biologycell cyclechemical biologychromosomecohesincondensationcondensinhumanmicrocephalinmouse

Identifiers

PMID34850681
PMCPMC8673838
OpenAlexW3217081400

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.